Skip to main content
. 2021 Mar 26;9:653450. doi: 10.3389/fpubh.2021.653450

Table 1.

Attributes and levels for the choice tasks.

Attributes Description to patients Levels and Level description Abridged general view
Progression-free survival It refers to the time from the start of treatment until the tumor appears to be further deteriorated; this study fixes the overall survival and gives a choice of progression-free survival over time. High
Medium
Low
11 months
8 months
5 months
Inline graphic
Inline graphic
Inline graphic
Disease control rate The number of cases with remission and stable lesions after treatment accounted for the number of cases that could be evaluated. High

Medium

Low
90%

75%

60%
Inline graphic

Inline graphic

Inline graphic
Rash Treatments can cause a varying degrees rash for as long as you take the treatment. None

Mild

Moderate
No rash

<1/10 of the body

more than 1/3 of the body
Inline graphic

Inline graphic

Inline graphic
Nausea and vomiting Treatments can cause nausea and vomiting as long as you take the treatment. Mild

Moderate

Severe
1 time in 24 h

2–5 times in 24 h

more than 6 times in 24 h
Inline graphic

Inline graphic

Inline graphic
Weakness and fatigue When you take the treatment you may feel even weaker or more tired. Mild



Moderate


Severe
It is difficult to do physical exercises such as climbing stairs or running.
Can't work and take care of yourself.
You need to remain in bed
Inline graphic


Inline graphic


Inline graphic
Cost How much will you pay for the treatment. High

Medium

Low
5 ten thousand per months
2.5 ten thousand per months
1 ten thousand per months
Inline graphic

Inline graphic

Inline graphic
Mode of administration In general, treatments can be administered by infusion or taken as pills. Infusion


Oral
Inline graphic


Inline graphic